Home/Filings/4/0001601830-24-000128
4//SEC Filing

Marriott Tina 4

Accession 0001601830-24-000128

CIK 0001601830other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 7:09 PM ET

Size

13.8 KB

Accession

0001601830-24-000128

Insider Transaction Report

Form 4
Period: 2024-08-15
Larson Tina Marriott
President and COO
Transactions
  • Tax Payment

    Class A Common Stock

    2024-08-15$6.69/sh14,319$95,794521,138 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $1.06Exp: 2028-07-22Class A Common Stock (0 underlying)
    470,000
  • Stock Option (Right to Buy)

    Exercise: $8.55Exp: 2033-02-01Class A Common Stock (0 underlying)
    434,122
  • Stock Option (Right to Buy)

    Exercise: $11.40Exp: 2032-02-04Class A Common Stock (0 underlying)
    159,226
  • Stock Option (Right to Buy)

    Exercise: $11.40From: 2022-02-04Exp: 2032-02-04Class A Common Stock (0 underlying)
    4,784
  • Stock Option (Right to Buy)

    Exercise: $2.48Exp: 2030-12-30Class A Common Stock (0 underlying)
    150,000
  • Stock Option (Right to Buy)

    Exercise: $10.09Exp: 2034-02-09Class A Common Stock (0 underlying)
    447,917
Footnotes (6)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
  • [F2]Twenty-Five percent (25%) of the shares subject to the award (the stock option grant was for a total of 765,000 shares prior to exercise) shall vest one year after July 16, 2018, or the Annual Vesting Commencement Date, and one-forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Annual Vesting Commencement Date.
  • [F3]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
  • [F4]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
  • [F5]One forty-eighth (1/48th) of the shares subject to the award shall vest one month after December 31, 2020, or the Monthly Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Monthly Vesting Commencement Date.
  • [F6]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1
  • filerCIK 0001856414

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 7:09 PM ET
Size
13.8 KB